Clincosm LogoSign in Get a demo

B-cell Non Hodgkin Lymphoma

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

Recruiting
  • B-Cell Non Hodgkin Lymphoma
  • B-Cell Acute Lymphoblastic Leukemia
  • anti-CD19 CAR T-cells
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023

B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • (no location specified)
Aug 7, 2023

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • regimen with BTK inhibitor +Anti-CD19 CAR T cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma, Relapsed
    • +8 more
    • PBCAR20A
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • CB dualCAR-NK19/70
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 25, 2022

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Korea, Republic of, United

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • +3 more
    • Tampa, Florida
    • +8 more
    Oct 17, 2022

    B Cell ALL, B-Cell Lymphoma, B-cell Non Hodgkin Lymphoma Trial in Hackensack, New York (Anakinra)

    Recruiting
    • B Cell ALL
    • +2 more
    • Hackensack, New Jersey
    • +1 more
    Aug 22, 2022

    B-cell Non Hodgkin Lymphoma, Richter's Transformation Trial in United States (Cosibelimab, Cosibelimab + Ublituximab +

    Terminated
    • B-cell Non Hodgkin Lymphoma
    • Richter's Transformation
    • Cosibelimab
    • Cosibelimab + Ublituximab + Bendamustine combination
    • Huntsville, Alabama
    • +8 more
    Aug 19, 2022

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (anti-CD19 CAR-NK)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • anti-CD19 CAR-NK
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jul 21, 2022

    Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))

    Recruiting
    • Multiple Myeloma
    • +13 more
    • RITA (App)
    • Milano, Italy
      ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
    Jul 6, 2022

    B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • B-cell Chronic Lymphocytic Leukemia
    • Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
    • +3 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin and Froedtert Hospital
    Jul 1, 2022

    B-cell Non Hodgkin Lymphoma Trial in Augsburg, Cologne, Hamburg (MB-CART2019.1 Dose level 1, MB-CART2019.1 Dose level 2)

    Active, not recruiting
    • B-cell Non Hodgkin Lymphoma
    • MB-CART2019.1 Dose level 1
    • MB-CART2019.1 Dose level 2
    • Augsburg, Bavaria, Germany
    • +2 more
    Jun 13, 2022

    B-cell Non Hodgkin Lymphoma Trial in Seoul (AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • AT101(Anti-CD19 Chimeric Antigen Receptor T cell)
    • Seoul, Korea, Republic of
      Asan Medical Center
    May 24, 2022

    B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor Trial in Edmonton, Toronto, Montréal (PCLX-001 treated)

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • Advanced Solid Tumor
    • PCLX-001 treated
    • Edmonton, Alberta, Canada
    • +2 more
    Feb 28, 2022

    Commercially Available Vaccines Against SARS-CoV-2 in

    Recruiting
    • Monoclonal B-Cell Lymphocytosis
    • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Feb 10, 2022

      B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL Trial in Stanford (Fludarabine, Cyclophosphamide, CD22 CAR)

      Recruiting
      • B-ALL
      • +3 more
      • Stanford, California
        Stanford Medical Center
      Jan 14, 2022

      High Grade B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements,

      Recruiting
      • High Grade B-Cell Lymphoma, Not Otherwise Specified
      • +4 more
      • Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTX
      • R-CHOP; R-DA-EPOCH; R-HD MTX
      • Jinan, Shandong, China
        Department of Hematology, Shandong Provincial Hospital
      Dec 7, 2021

      B-cell Non Hodgkin Lymphoma Trial in Hangzhou (anti-CD19 CAR-NK)

      Recruiting
      • B-cell Non Hodgkin Lymphoma
      • anti-CD19 CAR-NK
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      May 13, 2021

      B-Cell Non Hodgkin Lymphoma Trial in Worldwide (Blinatumomab)

      Completed
      Has Results
      • B-Cell Non Hodgkin Lymphoma
      • Duarte, California
      • +30 more
      Dec 18, 2020

      B-cell Non Hodgkin Lymphoma Trial in Sanhe (GC022F)

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • GC022F
      • Sanhe, Hebei, China
        Hebei Yanda Ludaopei Hospital
      Jun 1, 2020

      B-cell Non Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma Trial in Changsha (Novel CAR-T)

      Unknown status
      • B-cell Non Hodgkin Lymphoma
      • +2 more
      • Novel CAR-T
      • Changsha, Hunan, China
        Hunan Provincial People's Hospital
      Dec 6, 2019